Psykey, Inc. (CEOS)
OTCMKTS · Delayed Price · Currency is USD
0.0060
-0.0016 (-21.05%)
Aug 18, 2025, 2:49 PM EDT

Psykey Company Description

Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life.

The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market.

Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes.

The company was formerly known as CeCors, Inc. and changed its name to Psykey, Inc. in August 2021.

Psykey, Inc. was founded in 2002 and is based in Toronto, Canada.

Psykey, Inc.
CountryUnited States
Founded2002
IndustryMedical Instruments & Supplies
SectorHealthcare
Employees6
CEOMichael Maher

Contact Details

Address:
17 Belfield Road
Toronto, Nevada M9W1E8
Canada
Phone888 376 8258
Websitepsykeyworld.com

Stock Details

Ticker SymbolCEOS
ExchangeOTCMKTS
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
ISIN NumberUS1500431077
SIC Code3669

Key Executives

NamePosition
Michael MaherInterim Chief Executive Officer
Amar Singh BhatalCo-Founder, President, Secretary and Director
Sukhinderpaul KalsiCo-Founder, Chief Financial Officer, Treasurer and Director
Jacqueline Rae DanforthCompliance Officer and Accountant
Mark PerkellVice President and General Counsel
John GustinHead of Global Business Development